Evaluating retinopathy of prematurity screening guidelines for 24- to 27-week gestational age infants.

ABSTRACT:

Objective

To determine whether current retinopathy of prematurity (ROP) screening guidelines adequately identify treatable ROP in a contemporary cohort of extremely low gestation infants.

Study design

Data from the Surfactant, Positive Pressure, and Pulse Oximetry Randomized Trial were used. Inborn infants of 24 (0)/7 to 27 (6)/7 weeks gestational age (GA) with consent before delivery were enrolled in 2005 to 2009. Severe ROP (type 1 ROP or treatment with laser, cryotherapy or bevacizumab) or death was the primary outcome for the randomized trial. Examinations followed the then current AAP (American Academy of Pediatrics) screening recommendations, beginning by 31 to 33 weeks postmenstrual age (PMA).

Result

One thousand three hundred and sixteen infants were enrolled

SUBMITTER: Kennedy KA 

PROVIDER: S-EPMC3969774 | biostudies-literature | 2014 Apr

REPOSITORIES: biostudies-literature